Gene · 8205
Papers2,064
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,064
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Take my breath away: TAM-ing anti-cancer immunity in hypoxic niches. | Immunity | 2023 | 37557077 | PubTator, text mining | PubMed |
| Primary care engagement in health system change: a scoping review of common barriers and effective strategies. | BMC Prim Care | 2023 | 37550639 | PubTator, text mining | PubMed |
| Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK). | Kidney Int Rep | 2023 | 37547524 | PubTator, text mining | PubMed |
| Targeted degradation of MERTK and other TAM receptor paralogs by heterobifunctional targeted protein degraders. | Front Immunol | 2023 | 37545504 | PubTator, text mining | PubMed |
| ChemR23 activation reprograms macrophages toward a less inflammatory phenotype and dampens carcinoma progression. | Front Immunol | 2023 | 37539056 | PubTator, text mining | PubMed |
| Harnessing neutrophil plasticity for HCC immunotherapy. | Essays Biochem | 2023 | 37534829 | PubTator, text mining | PubMed |
| Therapeutic application of regeneration-associated cells: a novel source of regenerative medicine. | Stem Cell Res Ther | 2023 | 37533070 | PubTator, text mining | PubMed |
| Evaluating the Usefulness and Ease of Use of a Next-Generation-Connected Drug Delivery Device for Growth Hormone Therapy: Qualitative Study of Health Care Professionals' Perceptions. | JMIR Hum Factors | 2023 | 37531173 | PubTator, text mining | PubMed |
| Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy. | Breast | 2023 | 37517154 | PubTator, text mining | PubMed |
| Macrophage-Based Therapeutic Strategies in Hematologic Malignancies. | Cancers (Basel) | 2023 | 37509382 | PubTator, text mining | PubMed |
| Neutrophils in triple-negative breast cancer: an underestimated player with increasingly recognized importance. | Breast Cancer Res | 2023 | 37496019 | PubTator, text mining | PubMed |
| Baicalein enhances immune response in TNBC by inhibiting leptin expression of adipocytes. | Cancer Sci | 2023 | 37489486 | PubTator, text mining | PubMed |
| Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma. | Mol Cancer | 2023 | 37488598 | PubTator, text mining | PubMed |
| Investigation on sexual function in young breast cancer patients during endocrine therapy: a latent class analysis. | Front Med (Lausanne) | 2023 | 37484843 | PubTator, text mining | PubMed |
| Liver metastasis from colorectal cancer: pathogenetic development, immune landscape of the tumour microenvironment and therapeutic approaches. | J Exp Clin Cancer Res | 2023 | 37480104 | PubTator, text mining | PubMed |
| Rational social distancing in epidemics with uncertain vaccination timing. | PLoS One | 2023 | 37478107 | PubTator, text mining | PubMed |
| GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer. | J Hematol Oncol | 2023 | 37475048 | PubTator, text mining | PubMed |
| A new Gondwanan mayfly family from the Lower Cretaceous Crato Formation, Brazil (Ephemeroptera: Siphlonuroidea: Astraeopteridae fam. nov.). | Sci Rep | 2023 | 37474555 | PubTator, text mining | PubMed |
| Oncolytic viruses engineered to enforce cholesterol efflux restore tumor-associated macrophage phagocytosis and anti-tumor immunity in glioblastoma. | Nat Commun | 2023 | 37474548 | PubTator, text mining | PubMed |
| The Effect of Aromatherapy with Citrus aurantium Aroma on Pain after Orthopedic Surgery: A Randomized Clinical Trial. | J Caring Sci | 2023 | 37469751 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8205/papers?page=17